|By Nathan Young|
CVS is company that almost seems to be on every street corner. Being a top competitor to Walgreens, they have no choice but to be just as aggressive. CVS stores are a quick convince store as well as pharmacy and even minute clinics for your simple colds and flus. These are all around great stores, but as prices rise and shopping shifts to online retailers, could this be adversely affecting the company? Let us dive into some numbers to see if the trend supports potential investments.
Taking a look at the company’s numbers in an 8-K filing, we can see net revenues increased 15.5% to $44.6 billion, which is a year-over-year number. Operating profits increased 20.9% to $2.8 billion, which again, this is a year-over-year number. Year-to-date cash flow from operations is $7.9 billion and generated free cash flow of $6.6 billion. CVS does have a note for the 2017 fiscal year that their projections included a projected loss of more than 40 million retail prescriptions related to new restricted pharmacy networks.
Looking at the chart, it appears price seems to be falling a bit, as it is beginning to make lower highs and lower lows. Just like most stocks, the price has increase steadily for years and is now maybe being over extended. I would be watching for a healthy retrace and begin looking for a solid entry point if this is a stock you want to invest in. Right now, it appears a top has been made and now patience is key.
Taking a look at the 10-K filing, the first risk the company cites is that they are in a highly competitive business environment. It is evident with companies such as Walgreens that are attempting to execute that same business idea. To lower this risk, the company has to stay ahead of the curve and innovate quicker than competitors. The company also cites the overall market conditions could adversely affect the company. People will spend less knowing the health of the economy is deteriorating, in order to preserve their own wealth. Lastly, CVS has to maintain consumer security, as that is a very real risk. Target is the poster child for a large-scale data breech of customer information, and if that happens to a company such as CVS, they are sure to lose customers to other businesses.
Overall, CVS appears to be doing fundamentally well, but I would take a look at the chart to see if might be overpriced compared to others in the same sector. Take a deeper look into ratios and see where it compares, and find an appropriate entry point from there. As with any investment, be sure to consult an investing professional to ensure you financial goals are being met.
|This article from Macroaxis published on 06 of December contributed to the next trading period price escalation.The overall trading delta to the next next day price was 1.4% . The overall trading delta when the story was published to current price is 11.13% .|